[NH2:1][C:2]1[C:11]([CH2:12][C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)=[N:10][C:9]2[C:8]3[CH:19]=[CH:20][C:21]([O:23]C)=[CH:22][C:7]=3[CH:6]=[CH:5][C:4]=2[N:3]=1.Cl.[NH+]1C=CC=CC=1>O>[NH2:1][C:2]1[C:11]([CH2:12][C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)=[N:10][C:9]2[C:8]3[CH:19]=[CH:20][C:21]([OH:23])=[CH:22][C:7]=3[CH:6]=[CH:5][C:4]=2[N:3]=1A mixture of 3-amino-2-benzyl-8-methoxybenzo[f]quinoxaline (12) (125 mg, 396 μmol) and pyridinium hydrochloride (2.50 g, 21.6 mmol) was stirred at 190° C. (oil bath temperature) for 30 minutes and at 210° C. (oil bath temperature) for further 30 minutes. After cooling to room temperature, to the mixture was added water, the product was extracted with ethyl acetate (×3). The combined organic extract was washed successively with water (×1) and brine (×1), followed by drying over anhydrous sodium sulfate. After filtration and concentration under reduced pressure, the residue was purified by silica gel flash column chromatography (n-hexane/ethyl acetate=1/1→1/10) to give 3-amino-2-benzylbenzo[f]quinoxalin-8-ol (14, ν-coelenteramine) (55.5 mg, 184 μmol, 46.5%) as an ocherous solid.